Well they have a lot of help if you look at the sort of media coverage the company gets...
PolyNovo’s tumble, CEO’s exit leave room for improvement
The biotech appeared resilient to the headwinds of COVID-19, but the sudden exit of its CEO and more virus waves make the outlook hazy.
Regal’s Phil King was right on Polynovo ... eventually
- Nov 29, 2021
- Carrie LaFrenz
Though being early is the same as being wrong, particularly when leverage is involved.
Polynovo’s CEO resigns
- Nov 17, 2021
- Myriam Robin
Paul Brennan will remain as managing director for the next three months to assist with an orderly transfer of leadership.
PolyNovo sales growth slows as lockdowns hit surgery rates
- Nov 5, 2021
- Tom Richardson
Biotech company PolyNovo’s revenue grew 25.3 per cent for the first half, as it hit $12.8 million.
- Feb 23, 2021
- Yolanda Redrup
https://www."__".com/company/asx/pnv
That is "afr"
David Williams on Talk Ya Book with Chris Judd, page-109
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.07 |
Change
0.030(1.47%) |
Mkt cap ! $1.429B | |||
| Open | High | Low | Value | Volume |
| $2.11 | $2.12 | $2.05 | $2.783M | 1.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 19976 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.07 | 9633 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |